<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04733235</url>
  </required_header>
  <id_info>
    <org_study_id>AkdenizUKD</org_study_id>
    <nct_id>NCT04733235</nct_id>
  </id_info>
  <brief_title>the Effect of Endometrial Compaction Caused by Progesterone Effect on Pregnancy Outcomes</brief_title>
  <official_title>The Effect of Progesterone Induced Endometrial Compaction on Pregnancy Outcomes in Frozen-thawed Embryo Transfer at the Blastocyst Stage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akdeniz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akdeniz University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective cohort study is to assess the effect of endometrial&#xD;
      compaction caused by progesterone effect on pregnancy outcomes&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For a pregnancy to occur, the embryo must implant in a receptive endometrium during the&#xD;
      window of implantation, which is thought to occur from day 22 to 24 of an idealized 28-day&#xD;
      cycle. Early studies have suggested that assessing endometrial thickness with the use of&#xD;
      ultrasound may be an alternative to invasive techniques such as endometrial biopsy for&#xD;
      attempting to determine a receptive endometrium for frozen-thawed embryo transfer (FET).&#xD;
&#xD;
      A preovulatory endometrial thickness of 7 mm or more is considered to be the cutoff for&#xD;
      endometrial receptivity, below which many physicians would cancel an embryo transfer.&#xD;
      However, in most studies in the literature, endometrial thickness was measured either on the&#xD;
      day of hCG in fresh embryo transfer cases or on the last day of estrogen treatment in thawed&#xD;
      embryo transfers. There are a limited number of studies evaluating the luteal period, embryo&#xD;
      transfer day and endometrial thickness.&#xD;
&#xD;
      Accordingly, in this prospective cohort study is to assess the effect of endometrial&#xD;
      compaction caused by progesterone effect on pregnancy outcomes&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>The change in millimeters endometrial thickness and ongoing pregnancy rates.</measure>
    <time_frame>18 months</time_frame>
    <description>changing in millimeters of endometrial thickness at the end of the estrogen phase and the day of embryo transfer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo Transfer</measure>
    <time_frame>On the day of frozen embryo transfer</time_frame>
    <description>comparison of progesterone levels and endometrial thickness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>6-7 weeks after the last menstrual period of the patient</time_frame>
    <description>6th week gestational age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>5 weeks after the last menstrual period of the patient</time_frame>
    <description>Percentage of gestational sacs compared to the number of embryos transferred</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical miscarriage</measure>
    <time_frame>after 5th gestational week</time_frame>
    <description>pregnancy loss after ultrasonographic detection of an intrauterine gestational sac</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Infertility</condition>
  <condition>Female Infertility</condition>
  <condition>Frozen-thawed Embryo Transfer</condition>
  <arm_group>
    <arm_group_label>with endometrial compaction</arm_group_label>
    <description>Participants who have endometrial compaction caused by progesterone effects on undergoing frozen embryo transfer with artificial hormone replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without endometrial compaction</arm_group_label>
    <description>Participants who have not endometrial compaction caused by progesterone effects on undergoing frozen embryo transfer with artificial hormone replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Progesterone</intervention_name>
    <description>ultrasound measurements of endometrial thickness at the end of the estrogen phase and the day of embryo transfer.</description>
    <arm_group_label>with endometrial compaction</arm_group_label>
    <arm_group_label>without endometrial compaction</arm_group_label>
    <other_name>Diagnostic Test: Blood test Measurement of E2, P4, LH, FSH hormones Diagnostic Test: Transvaginal</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women underwent frozen embryo transfer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Woman aged 18-40 years&#xD;
&#xD;
          2. Presence of high quality (&gt;2BB) blastocyst&#xD;
&#xD;
          3. Hormonal(estrogen and progesterone) frozen- thawed embryo transfer cycles&#xD;
&#xD;
          4. presence of high quality blastocyst cryopreserved by vitrification method.&#xD;
&#xD;
          5. A single embryo transfer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of uterine pathology&#xD;
&#xD;
          2. Participants whose optimal endometrial image cannot be obtained due to uterine&#xD;
             position&#xD;
&#xD;
          3. Participants whose treatments were canceled for any reason before embryo transfer&#xD;
&#xD;
          4. Participants which had embryo transfer on the day 2 or 3 (at the cleavage stage)&#xD;
&#xD;
          5. Participants who had 2 embryo transfer&#xD;
&#xD;
          6. Presence of low quality (&lt;2BB) blastocyst&#xD;
&#xD;
          7. &gt; 15% loss of viability in the embryo during embryo thawing&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients underwent infertility treatment</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Şafak OLGAN, 1</last_name>
    <phone>506-406-87-40</phone>
    <email>safakolgan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saniye Merve GÜL KARA, 2</last_name>
    <phone>505-741-16-41</phone>
    <email>dr.smervegul@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Akdeniz University</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Şafak OLGAN, 1</last_name>
      <email>safakolgan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Saniye Merve GÜL KARA, 2</last_name>
      <phone>505-741-16-41</phone>
      <email>dr.smervegul@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>ŞAFAK OLGAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>GÜL KARA SANİYE MERVE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ÖZSİPAHİ ARİF CAN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Haas J, Smith R, Zilberberg E, Nayot D, Meriano J, Barzilay E, Casper RF. Endometrial compaction (decreased thickness) in response to progesterone results in optimal pregnancy outcome in frozen-thawed embryo transfers. Fertil Steril. 2019 Sep;112(3):503-509.e1. doi: 10.1016/j.fertnstert.2019.05.001. Epub 2019 Jun 24.</citation>
    <PMID>31248618</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 17, 2021</study_first_submitted>
  <study_first_submitted_qc>January 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 2, 2021</study_first_posted>
  <last_update_submitted>January 27, 2021</last_update_submitted>
  <last_update_submitted_qc>January 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Akdeniz University</investigator_affiliation>
    <investigator_full_name>ŞAFAK OLGAN</investigator_full_name>
    <investigator_title>ASSOCIATE PROFESSOR</investigator_title>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>female infertility</keyword>
  <keyword>frozen- thawed embryo transfer</keyword>
  <keyword>female</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

